Alembic Pharmaceuticals informs about press release

01 Dec 2022 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Diclofenac Sodium Topical Solution USP, 2% w/w. In this regard, the company has enclosed a press release.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

660.85 4.60 (0.70%)
20-Mar-2026 14:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1773.65
Dr. Reddys Lab 1301.95
Cipla 1254.65
Zydus Lifesciences 892.80
Lupin 2331.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×